PROGRAM CHAIRS
Alireza Atri, MD, PhD
Chief Medical Officer, Banner Research
Banner Alzheimer’s and Research Institutes
Phoenix, Sun City, and Tucson, AZ
Director, Banner Sun Health Research Institute
Sun City, Arizona
Brad Dickerson, MD, MMSc, FAAN
Director, Massachusetts General Hospital
Frontotemporal Disorders Unit
Professor of Neurology, Harvard Medical School
Boston, Massachusetts
FACULTY PRESENTER
Chi-Ying (Roy) Lin, MD, MPH, FAAN
Assistant Professor of Neurology
Baylor College of Medicine
Houston, Texas
PROGRAM OVERVIEW
This case-based educational activity is designed to enable providers who manage patients with Alzheimer’s disease (AD) to more effectively diagnose mild cognitive impairment (MCI) due to AD. Expert faculty will review updated criteria for screening, diagnosis, and staging; outline best practices for patient evaluation, including medical history and cognitive and diagnostic screening tools; and provide guidance on when to refer patients to specialists. Employing an interactive case-based learning platform, our faculty will assist learners with developing strategies to improve multidisciplinary and clinician/patient communication for shared decision making.
TARGET AUDIENCE
This activity is designed to meet the educational needs of health care providers involved in the diagnosis and continued care of patients with Alzheimer’s disease, including primary care physicians, neurologists, geriatricians, psychiatrists, nurses, NPs, PAs, and other multidisciplinary team members.
LEARNING OBJECTIVE
Upon the completion of this program, attendees should be able to:
- Integrate evidence-based pathways for screening, diagnosing, and staging MCI and AD
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credits commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this enduring activity for a maximum of 1.5 ANCC contact hours.
PHARMACISTS AND PHARMACY TECHNICIANS (ACPE) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.5 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
COMMISSION ON DIETETIC REGISTRATION (CDR) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 1.5 CPEU.
INTERPROFESSIONAL CONTINUING EDUCATION (IPCE) CREDIT DESIGNATION
This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credits for learning and change.
ASWB CREDIT DESIGNATION STATEMENT FOR JOINTLY ACCREDITED ORGANIZATIONS (SOCIAL WORKER CREDIT)
As a Jointly Accredited Organization, Med Learning Group is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit.
Social workers completing this course receive 1.5 synchronous continuing education credits.
AAPA CREDIT DESIGNATION STATEMENT – ENDURING MATERIALS
Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until June 26, 2026. PAs should only claim credit commensurate with the extent of their participation.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Faculty Member | Disclosures |
| Brad Dickerson, MD, MMSc, FAAN | Dr. Dickerson has nothing to disclose. |
| Alireza Atri, MD, PhD | Dr. Atri discloses that he has served as a consultant for Eisai, Lundbeck, Novo Nordisk, Life Molecular Imaging, Merck, ONO Pharma, and Prothena Biosciences. He has reported that he has received sponsored grant/research support paid to his institution from Alzheon, Athira Pharma, ATRI/USC, Arizona DHS, Eisai, Lilly, Life Molecular Imaging, Lundbeck, Vivoryon Therapeutics, Foundation for NIH, Gates Ventures, Washington University in St Louis, and NIA/NIH. He has provided presentations or lectures on behalf of and received travel or conference/meeting related support from the Alzheimer’s Association, and Alzheimer’s Disease International (ADI). He has received book royalties from Oxford University Press. |
| Chi-Ying (Roy) Lin, MD, MPH, FAAN | Dr. Lin has nothing to disclose. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity have reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
- Lauren Welch, MA, Sr VP of Operations for Med Learning Group, has nothing to disclose.
- Tom Bregartner, MBA, VP of Outcomes and Accreditation for Med Learning Group, has nothing to disclose.
- Surabhi Dangi-Garimella, PhD, Medical Director for Med Learning Group, has nothing to disclose.
- Joan Duer-Hefele, RN, MA, CCRC has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Lisa Crenshaw, Program Director for Med Learning Group, has nothing to disclose.
- Daniel DaSilva, Accreditation and Outcomes Coordinator, for Med Learning Group, has nothing to disclose.
- Jacquelyn Sandfort, Program Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
RELEASED DATE: June 30, 2025
EXPIRATION DATE: June 30, 2026
Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
